Archer Aviation Is Still Under $7. Here's Whether Long-Term Investors Should Pounce.

Archer Aviation reached 100% FAA acceptance of its Means of Compliance for the Midnight aircraft, while rival Joby remains at 97% after about three years. The article argues Archer’s outsourced manufacturing model and partnerships with Stellantis, Honeywell, and Molicel could help it scale faster and potentially generate more revenue than Joby within two years. Shares were cited at $6, about 25% above the 52-week low of $4.80 and around half of Joby’s valuation.

Analysis

The market is still pricing ACHR like a science project, but the acceptance milestone changes the probability tree: regulatory de-risking is now real, while execution risk shifts from certification to industrialization. That favors a partner-led model because the bottleneck in eVTOL is less about proving the aircraft can fly than proving you can build repeatable units, manage yields, and avoid working-capital blowups once orders convert into deliveries. In that sense, Archer’s supplier ecosystem is not just a cost choice; it is a speed-to-scale option that can create an earlier revenue inflection and reduce the need for dilutive capital raises.

The second-order winner may be STLA, which gets leveraged exposure to a plausible future platform without taking full aviation risk, while HON and Molicel become picks-and-shovels beneficiaries of an industry where qualification matters more than branding. If Archer’s approach works, it could also re-rate the whole supplier stack by proving that aerospace-adjacent manufacturing can be modularized enough to compress time-to-market. The flip side is that a modular supply chain can also become a chokepoint: any single vendor slip, battery shortfall, or thermal-control issue can delay certification-to-production conversion by quarters.

The key contrarian miss is that the spread between ACHR and JOBY may reflect different market beliefs about control versus scalability, not just progress on FAA paperwork. JOBY’s vertical integration may look slower today, but it preserves margin capture and may outperform once reliability and unit economics matter more than initial delivery speed. Over a 12-24 month horizon, the biggest risk to ACHR is not a headline setback; it is a lack of evidence that partner manufacturing can produce aviation-grade consistency at volume without hidden rework costs.

Near term, the stock remains a catalyst-driven trade rather than a fundamentals compounder, so upside can extend if the market starts capitalizing 2027 delivery optionality earlier. But if broader risk appetite fades, ACHR can retrace quickly because the current valuation still embeds a long runway before cash flow arrives. The setup is bullish, but it is a high-beta execution story where the path matters more than the destination.

Key Decisions for Investors

• Long ACHR vs short JOBY as a 6-12 month relative-value trade: thesis is that certification progress plus outsourced manufacturing should pull forward revenue visibility faster than JOBY’s vertically integrated model; stop if JOBY closes the operational gap with a new certification or production milestone.
• Buy ACHR on pullbacks toward support rather than strength-chase; size as a 1-2% portfolio pilot with 12-18 month horizon, because the rerating is likely to come in bursts tied to regulatory or manufacturing updates.
• Add STLA as a lower-volatility way to express eVTOL manufacturing upside over 6-24 months; risk/reward is attractive if investors begin valuing its partnership network as an embedded option on next-gen mobility.
• Use call spreads in ACHR instead of outright equity if expressing a catalyst view into the next 3-9 months; upside is tied to milestone-driven re-ratings, while downside remains meaningful if execution slips.
• Avoid sizing this as a broad long eVTOL basket without a short leg; the winner may take share, and the losers can lag badly if the market decides scale execution matters more than design pedigree.